Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to Dividend.com. Please help us personalize your experience.

Select the one that best describes you
Dividend logo

Healthcare is perhaps one of the most dynamic industries, full of opportunities for growth and stability.

For Dividend.com’s Best Dividend Stock List’s leading medical play, it’s managed to use both to its advantage. Having both an extensive portfolio of over-the-counter consumer products as well as a comprehensive catalog of state-of-art drugs and medical devices, our pick has continued to deliver rising free cash flows, earnings and, ultimately, dividend increases for investors. In fact, it’s raised its dividend twice, for a total of a 12% increase, since our addition back in May of last year.

See our original article on our pick here.

But our healthcare leader’s best days could be ahead of itself. After a series of major buyouts and M&A activities, our pick has refreshed its patent portfolio and set itself up to be a leader in a wide range of biotech drugs for tough-to-cure diseases. This should help drive future earnings and cash flows, all while keeping its moniker as a reigning dividend aristocrat.

To summarize, here are five reasons why you should own this stock:

  1. Dividend aristocrat that has raised its dividend for 54 years in a row.
  2. Massive patent portfolio of drugs, which has only gotten bigger through smart biotech M&A.
  3. Generated more than $15.5 billion in free cash flows last year alone.
  4. Operations in more than 80 countries and global leader in seven consumer healthcare categories.
  5. Low payout ratio of 46% and a healthy growing yield of 2.56%.
To read the Full Story, Go Premium or Log In

Popular Articles

Premium Trade%20war

The Market Wrap for May 25: The Trade War Is on Hold

Stocks turned bullish and the Dow pushed above the 25,000 mark once again early in the week as...


Trending: Teva Jumps as Buffett Increases Its Stake in the Company

Dividend.com analyzes the search patterns of our visitors each week. By sharing these trends with...

Premium Goldmansachs

Goldman’s Warning on Returns

Even the most stoic of long-term market participants must have seen the rise in volatility over...